share_log

Rosenblatt Reiterates Sell on CME Gr, Maintains $180 Price Target

Benzinga ·  Jan 4 08:47

Rosenblatt analyst Andrew Bond reiterates CME Gr (NASDAQ:CME) with a Sell and maintains $180 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment